HIPRA marks 25 years of activity in Portugal, celebrating a trajectory defined by science, innovation and strong specialization in prevention through advanced vaccines and diagnostic solutions. And in May, the subsidiary celebrated it together with its main distributors at an event held in Óbidos, north of Lisbon. 

As a biopharmaceutical company working under a One Health approach, HIPRA contributes to improving global health by addressing the interconnection between animal, human and environmental health. From its origins, HIPRA has based its development on a clear strategic choice: to invest in research, develop its own technology and place prevention at the core of its mission. 

Drawing on more than 50 years of experience in vaccine research and development, this strong scientific foundation has enabled the company to expand its international presence and contribute to both animal and human health through innovative vaccines and advanced solutions.

In Portugal, the celebration of these 25 years represents more than staying in the market. It reflects close collaboration with the sector, the construction of lasting partnerships and a consistent commitment to advancing animal and human health in the country. Throughout this journey, the Portuguese subsidiary stood out for its proximity to the people and the field, the technical preparation of its team and the alignment with the company's most demanding global standards. 

"Celebrating 25 years in Portugal is to recognize the path built together with our partners and reinforce the responsibility we assume daily with the sector. Prevention will continue to be the central axis of our action and our ambition for the future", says José Iglésias, Zone Director of HIPRA Iberia. 

By marking this milestone throughout the year, the company reaffirms its strategy of sustainable growth and its continuous commitment to scientific innovation as a driver of development.